Table 1 Cytotoxic activities of compounds 1 and 2 on HCT-116 and HepG2 cancer cell lines.

Cell line name	Conc. (µg/ml)	1			2
Cell line name	Conc. (µg/ml)	Viability %	IC₅₀ (µg/mL)	SI	Viability %	IC₅₀ (µg/mL)	SI
Wi38	100	58.93 ± 0.21	112.5 ± 3.42	--	49 ± 1.0	97.2 ± 2.14	--
	50	71.9 ± 0.95			64.33 ± 0.33
	25	80.83 ± 0.72			76.86 ± 0.69
	12.5	95.23 ± 0.67			90.33 ± 0.88
	6.25	99.66 ± 0.33			95 ± 1.0
	0	100 ± 0.0			100 ± 0.0
HCT-116	100	21.192 ± 0.2	11.8 ± 1.0	9.53	17.223 ± 0.43	10.4 ± 0.9	9.34
	50	24.077 ± 0.63			28.471 ± 0.29
	25	38.488 ± 0.86			34.094 ± 0.58
	12.5	55.184 ± 1.0			51.845 ± 0.66
	6.25	82.073 ± 0.4			72.583 ± 0.55
	0	100 ± 0.0			100 ± 0.0
HepG2	100	32.199 ± 0.69	8.8 ± 0.3	12.78	25.817 ± 0.78	12.0 ± 0.4	8.1
	50	32.185 ± 0.4			32.358 ± 0.81
	25	40.619 ± 0.37			46.471 ± 0.83
	12.5	52.323 ± 0.29			55.938 ± 0.52
	6.25	78.313 ± 0.78			81.755 ± 0.72
	0	100 ± 0.0			100 ± 0.0

Quick links

Search